Stock Price
13.59
Daily Change
-0.01 -0.04%
Monthly
-2.58%
Yearly
-46.87%
Q1 Forecast
13.18



Peers Price Chg Day Year Date
Amplifon 13.59 -0.01 -0.04% -46.87% Feb/02
Avanos Medical 13.56 0.24 1.80% -21.25% Feb/02
Brookdale Senior Living 16.00 1.00 6.63% 245.46% Feb/02
Cencora 362.52 3.30 0.92% 42.48% Feb/02
Diasorin 71.60 -0.58 -0.80% -30.82% Feb/02
Encompass Health 94.82 0.29 0.31% -5.73% Feb/02
Enovis 22.50 0.46 2.09% -50.30% Feb/02
GE HealthCare Technologies 79.80 0.83 1.05% -8.81% Feb/02
OPKO Health 391.30 2.10 0.54% -27.19% Feb/02
Zimmer Biomet Holdings 86.93 -0.14 -0.16% -19.63% Feb/02

Indexes Price Day Year Date
IT40 46122 491.31 1.08% 27.34% Feb/02
EU600 617 6.30 1.03% 15.42% Feb/02

Amplifon traded at 13.59 this Monday February 2nd, decreasing 0.01 or 0.04 percent since the previous trading session. Looking back, over the last four weeks, Amplifon lost 2.58 percent. Over the last 12 months, its price fell by 46.87 percent. Looking ahead, we forecast Amplifon to be priced at 13.18 by the end of this quarter and at 12.03 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).